Antigen Information
General Information of This Antigen
Antigen ID | TAR0KPFBI |
|||||
---|---|---|---|---|---|---|
Antigen Name | CD70 antigen (CD70) |
|||||
Gene Name | CD70 |
|||||
Gene ID | ||||||
Synonym | CD27L; CD27LG; TNFSF7; CD27 ligand;Tumor necrosis factor ligand superfamily member 7;CD_antigen=CD70 |
|||||
Sequence |
MPEEGSGCSVRRRPYGCVLRAALVPLVAGLVICLVVCIQRFAQAQQQLPLESLGWDVAEL
QLNHTGPQQDPRLYWQGGPALGRSFLHGPELDKGQLRIHRDGIYMVHIQVTLAICSSTTA SRHHPTTLAVGICSPASRSISLLRLSFHQGCTIASQRLTPLARGDTLCTNLTGTLLPSRN TDETFFGVQWVRP Click to Show/Hide
|
|||||
Family | Tumor necrosis factor family |
|||||
Function |
Cytokine which is the ligand for CD27. The CD70-CD27 pathway plays an important role in the generation and maintenance of T cell immunity, in particular during antiviral responses. Upon CD27 binding, induces the proliferation of costimulated T-cells and enhances the generation of cytolytic T-cells.
Click to Show/Hide
|
|||||
Uniprot Entry | ||||||
HGNC ID | ||||||
KEGG ID |
Each Antibody-drug Conjuate AND It's Component Related to This Antigen
Full List of The ADC Related to This Antigen
Anti-CD70 AMG172 mAb
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
AMG-172 |
Mertansine DM1 |
Microtubule (MT) |
Succinimidyl-4-(N-maleimidomethyl)cyclohexane-1-carboxylate (SMCC) |
[1] |
Anti-CD70 mAb
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
Anti-CD70-45 ADC |
Tetrahydroisoquinoline-based PBD dimer 17 |
Human Deoxyribonucleic acid (hDNA) |
Mc-Val-Cit-PABC |
[2] |
Anti-CD70 mAb 1F4
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
Anti-CD70 mAb 1F4-IIIa-01 |
Anti-CD70 mAb 1F4-IIIa-01 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIa-01 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIa-02 |
Anti-CD70 mAb 1F4-IIIa-02 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIa-02 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIa-03 |
Anti-CD70 mAb 1F4-IIIa-03 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIa-03 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIa-04 |
Anti-CD70 mAb 1F4-IIIa-04 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIa-04 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIa-05 |
Anti-CD70 mAb 1F4-IIIa-05 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIa-05 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIa-06 |
Anti-CD70 mAb 1F4-IIIa-06 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIa-06 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIa-07 |
Anti-CD70 mAb 1F4-IIIa-07 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIa-07 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIa-08 |
Anti-CD70 mAb 1F4-IIIa-08 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIa-08 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIb-01 |
Anti-CD70 mAb 1F4-IIIb-01 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIb-01 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIb-02 |
Anti-CD70 mAb 1F4-IIIb-02 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIb-02 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIb-03 |
Anti-CD70 mAb 1F4-IIIb-03 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIb-03 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIb-04 |
Anti-CD70 mAb 1F4-IIIb-04 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIb-04 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIb-05 |
Anti-CD70 mAb 1F4-IIIb-05 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIb-05 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIb-06 |
Anti-CD70 mAb 1F4-IIIb-06 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIb-06 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIb-07 |
Anti-CD70 mAb 1F4-IIIb-07 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIb-07 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIb-08 |
Anti-CD70 mAb 1F4-IIIb-08 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIb-08 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIb-09 |
Anti-CD70 mAb 1F4-IIIb-09 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIb-09 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIc-01 |
Anti-CD70 mAb 1F4-IIIc-01 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIc-01 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIc-02 |
Anti-CD70 mAb 1F4-IIIc-02 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIc-02 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIc-03 |
Anti-CD70 mAb 1F4-IIIc-03 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIc-03 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIc-04 |
Anti-CD70 mAb 1F4-IIIc-04 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIc-04 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIc-05 |
Anti-CD70 mAb 1F4-IIIc-05 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIc-05 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIc-06 |
Anti-CD70 mAb 1F4-IIIc-06 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIc-06 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIc-07 |
Anti-CD70 mAb 1F4-IIIc-07 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIc-07 linker |
[3] | |
Anti-CD70 mAb 1F4-IIIc-08 |
Anti-CD70 mAb 1F4-IIIc-08 payload |
Undisclosed |
Anti-CD70 mAb 1F4-IIIc-08 linker |
[3] | |
Anti-CD70 mAb 1F4-A |
Anti-CD70 mAb 1F4-A payload |
Undisclosed |
Anti-CD70 mAb 1F4 linker |
[3] |
Anti-CD70 mAb 2H5
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
Anti-CD70 ADC 12-2 |
Anti-CD70 ADC 12-2 payload |
Undisclosed |
Anti-CD70 ADC 12-2 linker |
[4] | |
Anti-CD70 ADC 2-7 |
Anti-CD70 ADC 2-7 payload |
Undisclosed |
Anti-CD70 ADC 2-7 linker |
[4] | |
Anti-CD70 ADC 3-4 |
Anti-CD70 ADC 3-4 payload |
Undisclosed |
Anti-CD70 ADC 3-4 linker |
[4] | |
Anti-CD70 ADC 4-3 |
Anti-CD70 ADC 4-3 payload |
Undisclosed |
Anti-CD70 ADC 4-3 linker |
[4] | |
Anti-CD70 ADC 5-3 |
Anti-CD70 ADC 5-3 payload |
Undisclosed |
Anti-CD70 ADC 5-3 linker |
[4] | |
Anti-CD70 ADC 6-2 |
Anti-CD70 ADC 6-2 payload |
Undisclosed |
Anti-CD70 ADC 6-2 linker |
[4] | |
Anti-CD70 ADC 7-1 |
Anti-CD70 ADC 7-1 payload |
Undisclosed |
Anti-CD70 ADC 7-1 linker |
[4] | |
Anti-CD70 ADC 8-5 |
Anti-CD70 ADC 8-5 payload |
Undisclosed |
Anti-CD70 ADC 8-5 linker |
[4] | |
Anti-CD70 ADC 9-4 |
Anti-CD70 ADC 9-4 payload |
Undisclosed |
Anti-CD70 ADC 9-4 linker |
[4] | |
Anti-CD70 ADC 10-1 |
Anti-CD70 ADC 10-1 payload |
Undisclosed |
Anti-CD70 ADC 10-1 linker |
[4] | |
Anti-CD70 ADC 11-5 |
Anti-CD70 ADC 11-5 payload |
Undisclosed |
Anti-CD70 ADC 11-5 linker |
[4] | |
Anti-CD70 ADC 12-3 |
Anti-CD70 ADC 12-3 payload |
Undisclosed |
Anti-CD70 ADC 12-3 linker |
[4] | |
Anti-CD70 ADC 13-7 |
Anti-CD70 ADC 13-7 payload |
Undisclosed |
Anti-CD70 ADC 13-7 linker |
[4] | |
Anti-CD70 ADC 14-5 |
Anti-CD70 ADC 14-5 payload |
Undisclosed |
Anti-CD70 ADC 14-5 linker |
[4] | |
Anti-CD70 ADC 15-5 |
Anti-CD70 ADC 15-5 payload |
Undisclosed |
Anti-CD70 ADC 15-5 linker |
[4] | |
Anti-CD70 ADC 16-5 |
Anti-CD70 ADC 16-5 payload |
Undisclosed |
Anti-CD70 ADC 16-5 linker |
[4] | |
Anti-CD70 ADC 17-2 |
Anti-CD70 ADC 17-2 payload |
Undisclosed |
Anti-CD70 ADC 17-2 linker |
[4] | |
Anti-CD70 ADC 18-3 |
Anti-CD70 ADC 18-3 payload |
Undisclosed |
Anti-CD70 ADC 18-3 linker |
[4] | |
Anti-CD70 ADC 19-5 |
Anti-CD70 ADC 19-5 payload |
Undisclosed |
Anti-CD70 ADC 19-5 linker |
[4] | |
Anti-CD70 ADC 21-5 |
Anti-CD70 ADC 21-5 payload |
Undisclosed |
Anti-CD70 ADC 21-5 linker |
[4] | |
Anti-CD70 ADC 20-5 |
Anti-CD70 ADC 20-5 payload |
Undisclosed |
Anti-CD70 ADC 20-5 linker |
[4] |
Anti-CD70 mAb c1F6
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2007011968A2 c1F6-9a |
Monomethyl auristatin E |
Microtubule (MT) |
WO2007011968A2_c1F6-9a linker |
[5] | |
WO2007011968A2 c1F6-9b |
Monomethyl auristatin F |
Microtubule (MT) |
WO2007011968A2_c1F6-9b linker |
[5] | |
WO2007011968A2 c1F6-17 |
Doxorubicin |
DNA topoisomerase 2-alpha (TOP2A) |
WO2007011968A2_c1F6-17 linker |
[5] |
Anti-CD70 mAb h1F6
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
WO2015095755A1 h1F6-1.3 |
Monomethyl auristatin E |
Microtubule (MT) |
WO2015095755A1_h1F6-1.3 linker |
[6] | |
WO2015095755A1 h1F6-1006 |
WO2015095755A1_h1F6-1006 payload |
Undisclosed |
WO2015095755A1_h1F6-1006 linker |
[6] | |
WO2015095755A1 h1F6-2.0 |
Monomethyl auristatin E |
Microtubule (MT) |
WO2015095755A1_h1F6-2.0 linker |
[6] | |
WO2015095755A1 h1F6-5.6 |
WO2015095755A1_h1F6-5.6 payload |
Undisclosed |
WO2015095755A1_h1F6-5.6 linker |
[6] | |
WO2015095755A1 h1F6-6.4 |
WO2015095755A1_h1F6-6.4 payload |
Undisclosed |
WO2015095755A1_h1F6-6.4 linker |
[6] | |
WO2015095755A1 h1F6-7.7 |
WO2015095755A1_h1F6-7.7 payload |
Undisclosed |
WO2015095755A1_h1F6-7.7 linker |
[6] |
Anti-CD70 mAb humanized 1F6
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
h1F6-Compound 1 |
h1F6-compound 1 payload |
Undisclosed |
h1F6-compound 1 linker |
[7] | |
h1F6-Compound 2 |
h1F6-compound 2 payload |
Undisclosed |
h1F6-compound 2 linker |
[7] | |
h1F6-Compound 3 |
h1F6-compound 3 payload |
Undisclosed |
h1F6-compound 3 linker |
[7] |
Anti-CD70 mAb IF6
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
1F6-Val-Cit-PABC-MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Mal-Val-Cit-PABC |
[8] | |
1F6-Ile-Pro-AF |
Auristatin F |
Microtubule (MT) |
Mal-Ile-Pro |
[8] | |
1F6-Me3-Lys-Pro-AF |
Auristatin F |
Microtubule (MT) |
Mal-Me3Lys-Pro |
[8] | |
1F6-NorVal- (D)Asp-AF |
Auristatin F |
Microtubule (MT) |
Mal-NorVal-D-Asp |
[8] | |
1F6-beta-Ala- (D)Asp-AF |
Auristatin F |
Microtubule (MT) |
Mal-bata-Ala-D-Asp |
[8] | |
1F6-PhenylGly- (D)Lys-AF |
Auristatin F |
Microtubule (MT) |
Mal-PhenylGly-D-Lys |
[8] | |
1F6-Met- (D)Lys-AF |
Auristatin F |
Microtubule (MT) |
Mal-Met-D-Lys |
[8] | |
1F6-Asn- (D)Lys-AM |
Auristatin M |
Microtubule (MT) |
Mal-Asn-D-Lys |
[8] | |
1F6-Met- (D)Lys-AW |
L-Alanyl-L-tryptophan |
Microtubule (MT) |
Mal-Met-D-Lys |
[8] | |
1F6-Ile-Val-AF |
Auristatin F |
Microtubule (MT) |
Mal-Ile-Val |
[8] | |
1F6-Asp-Val-AF |
Auristatin F |
Microtubule (MT) |
Mal-Asp-Val |
[8] | |
1F6-His-Val-AF |
Auristatin F |
Microtubule (MT) |
Mal-His-Val |
[8] | |
1F6-Met-Lys-AF |
Auristatin F |
Microtubule (MT) |
Mal-Met-Lys |
[8] | |
1F6-Asn-Lys-AF |
Auristatin F |
Microtubule (MT) |
Mal-Asn-Lys |
[8] | |
1F6-Pro- (D)Lys-AF |
Auristatin F |
Microtubule (MT) |
Mal-Pro-D-Lys |
[8] | |
1F6-Met- (D)Lys-MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Mal-Met-D-Lys |
[8] | |
1F6-Asn- (D)Lys-MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Mal-Asn-D-Lys |
[8] | |
1F6-Met- (D)Lys-AM |
Auristatin M |
Microtubule (MT) |
Mal-Met-D-Lys |
[8] | |
1F6-Asn- (D)Lys-AW |
L-Alanyl-L-tryptophan |
Microtubule (MT) |
Mal-Asn-D-Lys |
[8] | |
1F6-Asn- (D)Lys-AF |
Auristatin F |
Microtubule (MT) |
Mal-Asn-D-Lys |
[8] |
Anti-CD70 mAb murine 1F6
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
m1F6-Compound 1 |
m1F6-compound 1 payload |
Undisclosed |
m1F6-compound 1 linker |
[7] | |
m1F6-Compound 2 |
m1F6-compound 2 payload |
Undisclosed |
m1F6-compound 2 linker |
[7] | |
m1F6-Compound 3 |
m1F6-compound 3 payload |
Undisclosed |
m1F6-compound 3 linker |
[7] |
Chimeric Anti-CD70 Anti-ody
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
Alpha-CD70-Mc-MMAF |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[9] |
MDX-1115
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
MDX-1203 |
Seco-MED-A |
Human Deoxyribonucleic acid (hDNA) |
Mal-Val-Cit |
[10] |
Vorsetuzumab
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
CD70-MMAF-ADC |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
[11] | |
h1F6-mcMMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
[12] | |
h1F6-MC-vc-PABC-MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[12] | |
h1F6-MC-vc-PABC-MMAF DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[12] | |
h1F6-1 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Dpr-MA |
[12] | |
h1F6-1 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Dpr-MA |
[12] | |
h1F6-2 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Glu-Dpr-MA |
[12] | |
h1F6-2 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Glu-Dpr-MA |
[12] | |
h1F6-3 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Dpr-MA |
[12] | |
h1F6-3 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Dpr-MA |
[12] | |
h1F6-4 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-Dpr-MA |
[12] | |
h1F6-4 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-Dpr-MA |
[12] | |
h1F6-5 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Glu-Dpr-MDpr |
[12] | |
h1F6-5 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Glu-Dpr-MDpr |
[12] | |
h1F6-6 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-Dpr-MDpr |
[12] | |
h1F6-6 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-Dpr-MDpr |
[12] | |
h1F6-7 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-Lys-MDpr |
[12] | |
h1F6-7 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-Lys-MDpr |
[12] | |
h1F6-8 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Thiazole-Glu-Lys-MDpr |
[12] | |
h1F6-9 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Glu-EDA-MDpr |
[12] | |
h1F6-10 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Glu-EDA-MDpr |
[12] | |
h1F6-11 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Ile-EDA-MDpr |
[12] | |
h1F6-12 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Ile-EDA-MDpr |
[12] | |
h1F6-13 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Thiazole-Glu-EDA-MDpr |
[12] | |
h1F6-14 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Asp-Ala-Lys-MDpr |
[12] | |
h1F6-15 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Glu-Ala-Lys-MDpr |
[12] | |
h1F6-16 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
PhosphoThr-Ala-Lys-MDpr |
[12] | |
h1F6-17 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Asn-AlaGlu-Dpr-MDpr |
[12] | |
h1F6-18 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Glu-Ala-Glu-Dpr-MDpr |
[12] | |
h1F6-19 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Asp-AlaGlu-Dpr-MDpr |
[12] | |
h1F6-20 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Glu-Ala-Glu-Dpr-MDpr |
[12] | |
h1F6-21 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
hSer-Ala-Glu-Dpr-MDpr |
[12] | |
h1F6-22 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
ValoH-AlaGlu-Dpr-MDpr |
[12] | |
h1F6-23 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
PhosphoThr-Ala-Glu-Dpr-MDpr |
[12] | |
h1F6-24 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Pyrazole-Glu-Dpr-MDpr |
[12] | |
h1F6-25 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Triazole-Glu-Dpr-MDpr |
[12] | |
h1F6-26 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Asn-Glu-Dpr-MDpr |
[12] | |
h1F6-27 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Asp-Glu-Dpr-MDpr |
[12] | |
h1F6-28 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Fur-Glu-Dpr-MDpr |
[12] | |
h1F6-29 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
ValOH-Glu-Dpr-MDpr |
[12] | |
h1F6-30 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Ser-Glu-Dpr-MDpr |
[12] | |
h1F6-31 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
hSer-Glu-Dpr-MDpr |
[12] | |
h1F6-32 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-IleLeu-Dpr-MDpr |
[12] | |
h1F6-33 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Ile-Leu-Dpr-MDpr |
[12] | |
h1F6-34 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Glu-Phe-Leu-Dpr-MDpr |
[12] | |
h1F6-35 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-LeuPhe-Dpr-MDpr |
[12] | |
h1F6-36 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Leu-Phe-Dpr-MDpr |
[12] | |
h1F6-37 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Glu-Phe-Phe-Dpr-MDpr |
[12] | |
h1F6-38 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-LysAla-Dpr-MDpr |
[12] | |
h1F6-39 MMAE |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Lys-Dpr-MDpr |
[12] | |
h1F6-1 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Dpr-MA |
[12] | |
h1F6-2 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Glu-Dpr-MA |
[12] | |
h1F6-3 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Dpr-MA |
[12] | |
h1F6-4 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Glu-Dpr-MA |
[12] | |
h1F6-5 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Glu-Dpr-MDpr |
[12] | |
h1F6-6 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Glu-Dpr-MDpr |
[12] | |
h1F6-7 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Glu-Lys-MDpr |
[12] | |
h1F6-8 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thiazole-Glu-Lys-MDpr |
[12] | |
h1F6-9 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Glu-EDA-MDpr |
[12] | |
h1F6-10 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Glu-EDA-MDpr |
[12] | |
h1F6-11 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Ile-EDA-MDpr |
[12] | |
h1F6-12 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Ile-EDA-MDpr |
[12] | |
h1F6-13 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thiazole-Glu-EDA-MDpr |
[12] | |
h1F6-14 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Asp-Ala-Lys-MDpr |
[12] | |
h1F6-15 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Glu-Ala-Lys-MDpr |
[12] | |
h1F6-16 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
PhosphoThr-Ala-Lys-MDpr |
[12] | |
h1F6-17 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Asn-AlaGlu-Dpr-MDpr |
[12] | |
h1F6-18 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Glu-Ala-Glu-Dpr-MDpr |
[12] | |
h1F6-19 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Asp-AlaGlu-Dpr-MDpr |
[12] | |
h1F6-20 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Glu-Ala-Glu-Dpr-MDpr |
[12] | |
h1F6-21 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
hSer-Ala-Glu-Dpr-MDpr |
[12] | |
h1F6-22 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
ValoH-AlaGlu-Dpr-MDpr |
[12] | |
h1F6-23 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
PhosphoThr-Ala-Glu-Dpr-MDpr |
[12] | |
h1F6-24 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Pyrazole-Glu-Dpr-MDpr |
[12] | |
h1F6-25 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Triazole-Glu-Dpr-MDpr |
[12] | |
h1F6-26 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Asn-Glu-Dpr-MDpr |
[12] | |
h1F6-27 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Asp-Glu-Dpr-MDpr |
[12] | |
h1F6-28 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Fur-Glu-Dpr-MDpr |
[12] | |
h1F6-29 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
ValOH-Glu-Dpr-MDpr |
[12] | |
h1F6-30 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Ser-Glu-Dpr-MDpr |
[12] | |
h1F6-31 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
hSer-Glu-Dpr-MDpr |
[12] | |
h1F6-32 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-IleLeu-Dpr-MDpr |
[12] | |
h1F6-33 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Ile-Leu-Dpr-MDpr |
[12] | |
h1F6-34 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Glu-Phe-Leu-Dpr-MDpr |
[12] | |
h1F6-35 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-LeuPhe-Dpr-MDpr |
[12] | |
h1F6-36 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Phe-Leu-Phe-Dpr-MDpr |
[12] | |
h1F6-37 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Glu-Phe-Phe-Dpr-MDpr |
[12] | |
h1F6-38 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-LysAla-Dpr-MDpr |
[12] | |
h1F6-39 MMAF |
Monomethyl auristatin F |
Microtubule (MT) |
Thr-Lys-Dpr-MDpr |
[12] | |
h1F6-MC-vc-PABC-MMAF DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Mc-Val-Cit-PABC |
[12] | |
h1F6-13 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Thiazole-Glu-EDA-MDpr |
[12] | |
h1F6-12 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Thr-Ile-EDA-MDpr |
[12] | |
h1F6-11 MMAE DAR8 |
Monomethyl auristatin E |
Microtubule (MT) |
Phe-Ile-EDA-MDpr |
[12] | |
h1F6-17 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Asn-AlaGlu-Dpr-MDpr |
[12] | |
h1F6-20 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Glu-Ala-Glu-Dpr-MDpr |
[12] | |
h1F6-24 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
Pyrazole-Glu-Dpr-MDpr |
[12] | |
h1F6-29 MMAE DAR4 |
Monomethyl auristatin E |
Microtubule (MT) |
ValOH-Glu-Dpr-MDpr |
[12] | |
Vorsetuzumab mafodotin |
Monomethyl auristatin F |
Microtubule (MT) |
Maleimido-caproyl |
[13] |
Undisclosed
ADC Info | ADC Name | Payload | Target | Linker | Ref |
---|---|---|---|---|---|
PRO-1160 |
Exatecan |
DNA topoisomerase 1 (TOP1) |
Cys-11 ADC linker |
[14] | |
ARX-305 |
Undisclosed |
Undisclosed |
Undisclosed |
[15] | |
CD70-glucocorticoid ADC |
Fluticasone propionate |
Glucocorticoid receptor (NR3C1) |
Pyrophosphate linker |
[16] | |
Anti-CD70 antibody-drug conjugate (XDCExplorer) |
Undisclosed |
Undisclosed |
Undisclosed |
[17] | |
SGN-CD70A |
PBD dimer |
Human Deoxyribonucleic acid (hDNA) |
Undisclosed |
[18] |
Tissue/Disease specific Abundances of This Antigen
Tissue specific Abundances of This Antigen
ICD Disease Classification 01
Bacterial infection [ICD-11: 1A00-1C4Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Gingival | |
The Specific Disease | Bacterial infection of gingival | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 5.37E-09; Fold-change: 0.23750405; Z-score: 0.833646569 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 02
Brain cancer [ICD-11: 2A00]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Brainstem | |
The Specific Disease | Glioma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.944591191; Fold-change: -0.124328097; Z-score: -0.623539676 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | White matter | |
The Specific Disease | Glioma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.296821774; Fold-change: 0.008460034; Z-score: 0.0275707 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Brainstem | |
The Specific Disease | Neuroectodermal tumor | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.107396488; Fold-change: -0.240458099; Z-score: -0.760507704 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Nervous | |
The Specific Disease | Brain cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 1.22E-24; Fold-change: -0.201168492; Z-score: -0.780207153 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Chronic myeloid leukemia [ICD-11: 2A20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Polycythemia vera | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.256904399; Fold-change: 0.028415902; Z-score: 0.151097969 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Whole blood | |
The Specific Disease | Myelofibrosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.639824598; Fold-change: 0.052777286; Z-score: 0.307799235 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
MyeloDysplastic syndromes [ICD-11: 2A37]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Myelodysplastic syndromes | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.685058632; Fold-change: -0.015234703; Z-score: -0.069104482 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.06928947; Fold-change: -0.279343794; Z-score: -1.509558407 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Lymphoma [ICD-11: 2A90- 2A85]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Tonsil | |
The Specific Disease | Lymphoma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.03297748; Fold-change: -0.381742447; Z-score: -0.903711874 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Gastric cancer [ICD-11: 2B72]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Gastric | |
The Specific Disease | Gastric cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.634430958; Fold-change: -0.165798519; Z-score: -1.301898 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.599070617; Fold-change: 0.05906427; Z-score: 0.131697646 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Colon cancer [ICD-11: 2B90]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Colon | |
The Specific Disease | Colon cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 1.24E-06; Fold-change: 0.094885138; Z-score: 0.422294857 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.008232536; Fold-change: 0.064131693; Z-score: 0.231928031 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Pancreatic cancer [ICD-11: 2C10]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Pancreas | |
The Specific Disease | Pancreatic cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.154293126; Fold-change: -0.087780047; Z-score: -0.193735315 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 5.29E-09; Fold-change: -0.412074412; Z-score: -0.845854312 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Liver cancer [ICD-11: 2C12]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Liver | |
The Specific Disease | Liver cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 5.75E-10; Fold-change: -0.283005949; Z-score: -1.249430279 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 1.04E-18; Fold-change: -0.209691996; Z-score: -0.848284074 | |
The Expression Level of Disease Section Compare with the Other Disease Section | p-value: 0.059981678; Fold-change: -0.350218619; Z-score: -1.548397323 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Lung cancer [ICD-11: 2C25]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Lung | |
The Specific Disease | Lung cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.553534995; Fold-change: 0.041268023; Z-score: 0.134326403 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.003968516; Fold-change: 0.032888585; Z-score: 0.123779959 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Melanoma [ICD-11: 2C30]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Melanoma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.743977343; Fold-change: -0.175865047; Z-score: -0.427961713 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sarcoma [ICD-11: 2C35]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Muscle | |
The Specific Disease | Sarcoma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.000451932; Fold-change: -0.145394142; Z-score: -0.404159227 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.022315819; Fold-change: -0.347372729; Z-score: -2.68782675 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Breast cancer [ICD-11: 2C60]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Breast | |
The Specific Disease | Breast cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.885048994; Fold-change: 0.085923668; Z-score: 0.212718805 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.71651679; Fold-change: 0.091508804; Z-score: 0.27284419 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Ovarian cancer [ICD-11: 2C73]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Ovarian | |
The Specific Disease | Ovarian cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.813029236; Fold-change: 0.009587821; Z-score: 0.030097291 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 2.87E-06; Fold-change: 0.266657282; Z-score: 1.702349205 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Cervical cancer [ICD-11: 2C77]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Cervical | |
The Specific Disease | Cervical cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 8.07E-08; Fold-change: 0.219803323; Z-score: 1.338098708 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Uterine cancer [ICD-11: 2C78]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Endometrium | |
The Specific Disease | Uterine cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 1.69E-18; Fold-change: 0.30938461; Z-score: 1.041461445 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.015320501; Fold-change: 0.071001107; Z-score: 0.71137971 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Prostate cancer [ICD-11: 2C82]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Prostate | |
The Specific Disease | Prostate cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.000128867; Fold-change: -0.529515252; Z-score: -1.524134541 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Bladder cancer [ICD-11: 2C94]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bladder | |
The Specific Disease | Bladder cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.240056403; Fold-change: 0.100707108; Z-score: 0.671577104 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Retina cancer [ICD-11: 2D02]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Uvea | |
The Specific Disease | Retinoblastoma tumor | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.128374573; Fold-change: 0.129806686; Z-score: 0.911268646 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Thyroid cancer [ICD-11: 2D10]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Thyroid | |
The Specific Disease | Thyroid cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 3.60E-09; Fold-change: 0.174188158; Z-score: 0.526053819 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 1.74E-13; Fold-change: 0.224938282; Z-score: 1.337005465 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Adrenal cancer [ICD-11: 2D11]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Adrenal cortex | |
The Specific Disease | Adrenocortical carcinoma | |
The Expression Level of Disease Section Compare with the Other Disease Section | p-value: 0.638833026; Fold-change: -0.026805528; Z-score: -0.190257033 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Head and neck cancer [ICD-11: 2D42]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Head and neck | |
The Specific Disease | Head and neck cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 6.74E-12; Fold-change: 0.268481975; Z-score: 0.958367452 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Pituitary cancer [ICD-11: 2F37]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Pituitary | |
The Specific Disease | Pituitary gonadotrope tumor | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.445422064; Fold-change: -0.026463497; Z-score: -0.145436792 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Pituitary | |
The Specific Disease | Pituitary cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.049324001; Fold-change: 0.057461193; Z-score: 0.289861841 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 03
Thrombocytopenia [ICD-11: 3B64]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Thrombocytopenia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.676480355; Fold-change: 0.041811326; Z-score: 0.068350163 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 04
Lupus erythematosus [ICD-11: 4A40]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Lupus erythematosus | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.421348307; Fold-change: 0.012197138; Z-score: 0.02482372 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Autoimmune disease [ICD-11: 4A4Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral monocyte | |
The Specific Disease | Autoimmune uveitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.107819953; Fold-change: -0.161364812; Z-score: -2.031869674 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 05
Hyperlipoproteinaemia [ICD-11: 5C80]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Familial hypercholesterolemia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.034517818; Fold-change: -0.188379494; Z-score: -0.652847613 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 06
Schizophrenia [ICD-11: 6A20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Superior temporal cortex | |
The Specific Disease | Schizophrenia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.325489898; Fold-change: 0.00289254; Z-score: 0.021550329 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 08
Multiple sclerosis [ICD-11: 8A40]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Spinal cord | |
The Specific Disease | Multiple sclerosis | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.181533279; Fold-change: -0.066263277; Z-score: -0.897859436 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Plasmacytoid dendritic cells | |
The Specific Disease | Multiple sclerosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.179794171; Fold-change: 0.109279428; Z-score: 0.456649907 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Epilepsy [ICD-11: 8A60]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peritumoral cortex | |
The Specific Disease | Epilepsy | |
The Expression Level of Disease Section Compare with the Other Disease Section | p-value: 0.921399797; Fold-change: -0.063190059; Z-score: -0.359965999 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Cerebral ischaemic stroke [ICD-11: 8B11]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Cardioembolic Stroke | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.028592619; Fold-change: -0.102468728; Z-score: -0.600367449 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Peripheral blood | |
The Specific Disease | Ischemic stroke | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.054246247; Fold-change: -0.0683143; Z-score: -0.419415852 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 1
HIV [ICD-11: 1C60-1C62]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | White matter | |
The Specific Disease | HIV | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.650052834; Fold-change: -0.016599487; Z-score: -0.157926573 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Influenza [ICD-11: 1E30]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Influenza | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.098930452; Fold-change: 0.462346823; Z-score: 1.240312163 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Chronic hepatitis C [ICD-11: 1E51.1]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Chronic hepatitis C | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.855587537; Fold-change: 0.044065782; Z-score: 0.178161975 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sepsis [ICD-11: 1G40-1G41]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Sepsis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.401187587; Fold-change: -0.025202715; Z-score: -0.098670256 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Septic shock [ICD-11: 1G41]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Septic shock | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.478968668; Fold-change: -0.022392567; Z-score: -0.086589329 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Pediatric respiratory syncytial virus infection [ICD-11: CA40.11]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Pediatric respiratory syncytial virus infection | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.592109307; Fold-change: 0.030463482; Z-score: 0.206999056 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 11
Essential hypertension [ICD-11: BA00]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Essential hypertension | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.214990384; Fold-change: 0.39378589; Z-score: 1.499472431 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Myocardial infarction [ICD-11: BA41]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Myocardial infarction | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.341724863; Fold-change: 0.165425348; Z-score: 0.322484785 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Coronary artery disease [ICD-11: BA8Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Coronary artery disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.498161652; Fold-change: -0.112685735; Z-score: -0.547068076 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Aortic stenosis [ICD-11: BB70]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Calcified aortic valve | |
The Specific Disease | Aortic stenosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.259719701; Fold-change: 0.057464388; Z-score: 0.202998545 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Arteriosclerosis [ICD-11: BD40]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Arteriosclerosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.065366303; Fold-change: 0.090565972; Z-score: 0.462078942 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Aneurysm [ICD-11: BD50]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Intracranial artery | |
The Specific Disease | Aneurysm | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.647587712; Fold-change: -0.088139256; Z-score: -0.305972652 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 12
Immunodeficiency [ICD-11: 4A00-4A20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Immunodeficiency | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.237691864; Fold-change: 0.117713429; Z-score: 0.947907172 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Apnea [ICD-11: 7A40]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Hyperplastic tonsil | |
The Specific Disease | Apnea | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.10858373; Fold-change: -0.202455955; Z-score: -0.994942514 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Olive pollen allergy [ICD-11: CA08.00]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Olive pollen allergy | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.006472113; Fold-change: 0.260031861; Z-score: 3.373450789 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Chronic rhinosinusitis [ICD-11: CA0A]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Sinus mucosa | |
The Specific Disease | Chronic rhinosinusitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.033692129; Fold-change: 0.101551121; Z-score: 0.71789763 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Chronic obstructive pulmonary disease [ICD-11: CA22]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Lung | |
The Specific Disease | Chronic obstructive pulmonary disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.288189846; Fold-change: 0.105397164; Z-score: 0.448875397 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Small airway epithelium | |
The Specific Disease | Chronic obstructive pulmonary disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 6.35E-05; Fold-change: 0.209170532; Z-score: 0.969029734 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Asthma [ICD-11: CA23]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Nasal and bronchial airway | |
The Specific Disease | Asthma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.552177907; Fold-change: -0.057484319; Z-score: -0.230938717 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Human rhinovirus infection [ICD-11: CA42]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Nasal Epithelium | |
The Specific Disease | Human rhinovirus infection | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.917896705; Fold-change: -0.022405905; Z-score: -0.201375919 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Idiopathic pulmonary fibrosis [ICD-11: CB03.4]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Lung | |
The Specific Disease | Idiopathic pulmonary fibrosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.185426239; Fold-change: -0.181575027; Z-score: -1.106974531 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 13
Periodontal disease [ICD-11: DA0C]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Gingival | |
The Specific Disease | Periodontal disease | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 1.07E-09; Fold-change: 0.221882032; Z-score: 0.844108601 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Eosinophilic gastritis [ICD-11: DA42.2]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Gastric antrum | |
The Specific Disease | Eosinophilic gastritis | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.021676621; Fold-change: 0.135963038; Z-score: 1.801565879 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Liver failure [ICD-11: DB99.7-DB99.8]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Liver | |
The Specific Disease | Liver failure | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.068424499; Fold-change: -0.132991049; Z-score: -0.796388136 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Ulcerative colitis [ICD-11: DD71]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Colon mucosal | |
The Specific Disease | Ulcerative colitis | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.896623955; Fold-change: 0.162674831; Z-score: 0.415945862 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Irritable bowel syndrome [ICD-11: DD91.0]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Rectal colon | |
The Specific Disease | Irritable bowel syndrome | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.677179844; Fold-change: 0.000165601; Z-score: 0.000871468 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 14
Atopic dermatitis [ICD-11: EA80]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Atopic dermatitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.079279291; Fold-change: -0.090628259; Z-score: -0.616771124 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Psoriasis [ICD-11: EA90]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Psoriasis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 4.92E-14; Fold-change: -0.497514186; Z-score: -0.974353583 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 6.17E-14; Fold-change: 0.704554845; Z-score: 1.789309817 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Vitiligo [ICD-11: ED63.0]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Vitiligo | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.226227075; Fold-change: 0.252847427; Z-score: 0.615901171 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Alopecia [ICD-11: ED70]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin from scalp | |
The Specific Disease | Alopecia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.583909856; Fold-change: 0.023311594; Z-score: 0.122729509 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sensitive skin [ICD-11: EK0Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Sensitive skin | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.778250493; Fold-change: -0.005586626; Z-score: -0.134955402 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 15
Osteoarthritis [ICD-11: FA00-FA0Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Synovial | |
The Specific Disease | Osteoarthritis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.599844122; Fold-change: -0.103086567; Z-score: -0.216837057 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Arthropathy [ICD-11: FA00-FA5Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Arthropathy | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.785369427; Fold-change: -0.008663818; Z-score: -0.056500574 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Arthritis [ICD-11: FA20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Arthritis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.000446547; Fold-change: 0.152238645; Z-score: 0.606474752 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Rheumatoid arthritis [ICD-11: FA20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Synovial | |
The Specific Disease | Rheumatoid arthritis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.565643772; Fold-change: -0.124030352; Z-score: -0.180244594 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Ankylosing spondylitis [ICD-11: FA92.0Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Pheripheral blood | |
The Specific Disease | Ankylosing spondylitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.044832891; Fold-change: -0.139964854; Z-score: -1.332955578 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Osteoporosis [ICD-11: FB83]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Osteoporosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.859618754; Fold-change: 0.281041969; Z-score: 0.299172031 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 16
Endometriosis [ICD-11: GA10]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Endometrium | |
The Specific Disease | Endometriosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.883536692; Fold-change: 0.022824831; Z-score: 0.080629273 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Interstitial cystitis [ICD-11: GC00.3]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bladder | |
The Specific Disease | Interstitial cystitis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.002032443; Fold-change: 0.295260568; Z-score: 2.274319635 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 19
Preterm birth [ICD-11: KA21.4Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Myometrium | |
The Specific Disease | Preterm birth | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.042769547; Fold-change: -0.23289768; Z-score: -0.88558886 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 2
Acute myelocytic leukemia [ICD-11: 2A60]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Acute myelocytic leukemia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 4.07E-15; Fold-change: 0.119651191; Z-score: 0.57864228 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Myeloma [ICD-11: 2A83]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Myeloma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.022460893; Fold-change: 0.169054939; Z-score: 0.818982916 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Peripheral blood | |
The Specific Disease | Myeloma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.908750874; Fold-change: 0.143886814; Z-score: 0.10180355 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Oral cancer [ICD-11: 2B6E]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Oral | |
The Specific Disease | Oral cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.007228515; Fold-change: -0.215545871; Z-score: -0.543880304 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.000166678; Fold-change: 0.19945083; Z-score: 0.583791451 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Esophagal cancer [ICD-11: 2B70]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Esophagus | |
The Specific Disease | Esophagal cancer | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.645077252; Fold-change: -0.092107949; Z-score: -0.528294333 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Rectal cancer [ICD-11: 2B92]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Rectal colon | |
The Specific Disease | Rectal cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.720450651; Fold-change: -0.011888992; Z-score: -0.092315299 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.378679409; Fold-change: 0.103319986; Z-score: 0.379697184 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Skin cancer [ICD-11: 2C30-2C3Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Skin cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 9.18E-15; Fold-change: -0.60670709; Z-score: -1.042532844 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 4.32E-09; Fold-change: 0.399857001; Z-score: 0.73247132 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Renal cancer [ICD-11: 2C90-2C91]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Kidney | |
The Specific Disease | Renal cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 1.53E-09; Fold-change: 0.760442618; Z-score: 2.838597859 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 1.55E-15; Fold-change: 0.530662477; Z-score: 1.223808077 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Ureter cancer [ICD-11: 2C92]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Urothelium | |
The Specific Disease | Ureter cancer | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.691774325; Fold-change: 0.024357467; Z-score: 0.111240685 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 20
Simpson golabi behmel syndrome [ICD-11: LD2C]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Adipose | |
The Specific Disease | Simpson golabi behmel syndrome | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.326468562; Fold-change: 0.058558833; Z-score: 0.529156537 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Tuberous sclerosis complex [ICD-11: LD2D.2]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Perituberal | |
The Specific Disease | Tuberous sclerosis complex | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.67771948; Fold-change: 0.004732237; Z-score: 0.047335724 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 3
Anemia [ICD-11: 3A00-3A9Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Bone marrow | |
The Specific Disease | Anemia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.025303891; Fold-change: 0.187789279; Z-score: 1.067160433 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sickle cell disease [ICD-11: 3A51.0-3A51.3]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Sickle cell disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.72619028; Fold-change: 0.148298157; Z-score: 0.485448848 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Thrombocythemia [ICD-11: 3B63]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Thrombocythemia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.785294764; Fold-change: -0.031117895; Z-score: -0.163755511 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 4
Scleroderma [ICD-11: 4A42.Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Scleroderma | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.453749139; Fold-change: -0.035554451; Z-score: -0.164904834 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Sjogren syndrome [ICD-11: 4A43]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Salivary gland | |
The Specific Disease | Sjogren syndrome | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.388523644; Fold-change: -0.025261953; Z-score: -0.240341034 | |
The Expression Level of Disease Section Compare with the Adjacent Tissue | p-value: 0.100650162; Fold-change: -0.263039421; Z-score: -1.48428833 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Behcet disease [ICD-11: 4A62]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Peripheral blood | |
The Specific Disease | Behcet disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.084057543; Fold-change: -0.090100616; Z-score: -0.479130433 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Autosomal dominant monocytopenia [ICD-11: 4B04]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Autosomal dominant monocytopenia | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.857148566; Fold-change: 0.027523232; Z-score: 0.159531958 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 5
Type 2 diabetes [ICD-11: 5A11]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Liver | |
The Specific Disease | Type 2 diabetes | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.810479208; Fold-change: -0.038589129; Z-score: -0.300335612 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Polycystic ovary syndrome [ICD-11: 5A80.1]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Vastus lateralis muscle | |
The Specific Disease | Polycystic ovary syndrome | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.22461013; Fold-change: -0.064156387; Z-score: -0.402103219 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Obesity [ICD-11: 5B81]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Subcutaneous Adipose | |
The Specific Disease | Obesity | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.701099178; Fold-change: 0.044226419; Z-score: 0.150109647 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Pompe disease [ICD-11: 5C51.3]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Biceps muscle | |
The Specific Disease | Pompe disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.19172148; Fold-change: -0.212133177; Z-score: -1.137335211 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Batten disease [ICD-11: 5C56.1]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Batten disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.53945386; Fold-change: 0.007080026; Z-score: 0.087764489 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 6
Autism [ICD-11: 6A02]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Autism | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.027437606; Fold-change: -0.133990608; Z-score: -0.631734306 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Anxiety disorder [ICD-11: 6B00-6B0Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Anxiety disorder | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.251525355; Fold-change: -0.011369707; Z-score: -0.04812893 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
ICD Disease Classification 8
Parkinson disease [ICD-11: 8A00]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Substantia nigra | |
The Specific Disease | Parkinson disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.816749426; Fold-change: 0.051519886; Z-score: 0.177510847 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Huntington disease [ICD-11: 8A01]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Huntington disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.896760134; Fold-change: 0.043644093; Z-score: 0.195416356 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Alzheimer disease [ICD-11: 8A20]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Entorhinal cortex | |
The Specific Disease | Alzheimer disease | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.54206812; Fold-change: -0.021169133; Z-score: -0.150616497 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Seizure [ICD-11: 8A60-8A6Z]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Whole blood | |
The Specific Disease | Seizure | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.584043066; Fold-change: 0.023330874; Z-score: 0.11344192 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Lateral sclerosis [ICD-11: 8B60.4]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Skin | |
The Specific Disease | Lateral sclerosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.884547504; Fold-change: 0.042495384; Z-score: 0.254134797 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
The Studied Tissue | Cervical spinal cord | |
The Specific Disease | Lateral sclerosis | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.002169567; Fold-change: 0.244236706; Z-score: 1.492422026 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Muscular atrophy [ICD-11: 8C70]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Muscle | |
The Specific Disease | Muscular atrophy | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 3.68E-06; Fold-change: -0.504548695; Z-score: -2.217506406 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
Myopathy [ICD-11: 8C70.6]
Differential expression pattern of antigen in diseases | ||
The Studied Tissue | Muscle | |
The Specific Disease | Myopathy | |
The Expression Level of Disease Section Compare with the Healthy Individual Tissue | p-value: 0.042628875; Fold-change: -0.279224546; Z-score: -1.490340166 | |
Disease-specific Antigen Abundances | Click to View the Clearer Original Diagram | |
References
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.